Exhibit 107
Calculation of Filing Fee Tables
| | |
| Form S-8 |
| (Form Type) |
| Editas Medicine, Inc. |
| (Exact Name of Registrant as Specified in its Charter) |
Table 1—Newly Registered Securities
| | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
| Equity | Common Stock, $0.0001 par value per share | Other | 2,923,076 shares (2) | $1.82 (3) | $5,319,998.32 (3) | $153.10 per $1,000,000 | $814.50 |
| Total Offering Amounts | | $5,319,998.32 | | $814.50 |
| Total Fee Offsets | | | | — |
| Net Fee Due | | | | $814.50 |
| | | | | |
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| |
| (2) | Consists of additional shares issuable under the Editas Medicine, Inc. 2015 Stock Incentive Plan (the “2015 Stock Incentive Plan”). |
| |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, and based upon the average of the high and low sale prices of the common stock, $0.0001 par value per share (the "Common Stock"), of the Registrant as reported on the Nasdaq Global Select Market on February 28, 2025 for the additional shares issuable under the 2015 Stock Incentive Plan. |
